Governance

Overview

Access to Free of Charge Drugs Outside of Clinical Trials (via Access Schemes or Early Access to Medicine Schemes) v3

Organisational Structure and Governance Processes for a Central Collaborative Team Supporting the Maintenance of Oncological Treatment Guidelines (treatment algorithms) and Systemic Anti-Cancer Therapy (SACT) Protocols in Oncology and Haematology across the Kent and Medway Cancer Collaborative v11

Guidance on capping of BSA for the purposes of calculating cytotoxic chemotherapy v2

Policy for the Management of Algorithm deviations and the use of unfunded medicines which form part of treatment algorithms as defined in the Oncological Treatment Guidelines v7

SOPs

SOP-001 Standard Operating Procedure for the Maintenance of the Kent and Medway Cancer Collaborative (KMCC) Regimens Spreadsheets for Oncology and Haematology v1

SOP-003 Standard Operating Procedure for the Development (or Update) and Approval of Kent & Medway Oncological Treatment Guidelines v2

SOP-004 Standard Operating Procedure for the Development (or Update) and Approval of Systemic Anticancer Therapy Protocols (SACT) v4